|
|
Volumn 33, Issue 1-2, 2001, Pages 1196-1197
|
|
CMV in kidney transplants in the tacrolimus-mycophenolate era
a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
CYCLOSPORIN;
GANCICLOVIR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
TACROLIMUS;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
HUMAN;
INFECTION RISK;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
GANCICLOVIR;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
RETROSPECTIVE STUDIES;
TACROLIMUS;
|
|
EID: 0035077389
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02383-6 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (2)
|
